Chembond Material Technologies Ltd

Chembond Material Technologies Ltd

₹ 182 1.42%
10 Jul - close price
About

Incorporated in 1974, Chembond Chemicals Ltd manufactures and sells specialty chemicals and animal health products.[1]

Key Points

Business Overview[1][2]
Chembond Material Technologies Limited manufactures specialty chemicals, including automotive sealants, engineering adhesives, metal treatment chemicals, high-performance coatings, and animal health & industrial biotech products. The Company serves diverse industries through its manufacturing facilities, R&D capabilities, and internationally certified quality systems.

  • Market Cap 245 Cr.
  • Current Price 182
  • High / Low 235 / 105
  • Stock P/E 37.7
  • Book Value 127
  • Dividend Yield 1.10 %
  • ROCE 4.96 %
  • ROE 3.90 %
  • Face Value 5.00

Pros

  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 27.4%

Cons

  • Company has a low return on equity of 6.01% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
14.55 14.32 12.33 12.40 40.50 39.56 43.02 44.18 44.44 48.92 48.93 52.21 60.08
13.76 14.26 12.05 13.02 37.34 35.40 40.32 40.99 41.34 46.27 46.24 49.97 55.31
Operating Profit 0.79 0.06 0.28 -0.62 3.16 4.16 2.70 3.19 3.10 2.65 2.69 2.24 4.77
OPM % 5.43% 0.42% 2.27% -5.00% 7.80% 10.52% 6.28% 7.22% 6.98% 5.42% 5.50% 4.29% 7.94%
1.02 2.63 3.76 2.49 0.89 2.08 5.16 -0.22 1.72 2.65 0.12 -0.16 -1.11
Interest 0.01 0.02 0.01 0.02 0.08 0.03 0.03 0.02 0.01 0.05 0.03 0.04 0.01
Depreciation 0.60 0.61 0.65 0.61 0.87 0.56 0.68 0.67 0.69 0.67 1.19 0.80 0.84
Profit before tax 1.20 2.06 3.38 1.24 3.10 5.65 7.15 2.28 4.12 4.58 1.59 1.24 2.81
Tax % 28.33% -8.25% 24.56% -20.97% 45.16% 2.12% 11.33% -5.26% 28.16% 30.57% -65.41% 96.77% 32.03%
0.86 2.23 2.54 1.50 1.70 5.52 6.34 2.40 2.97 3.17 2.63 0.04 1.91
EPS in Rs 0.64 1.66 1.90 1.12 1.27 4.12 4.73 1.79 2.22 2.37 1.96 0.03 1.43
Raw PDF
Upcoming result date: 17 July 2026

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
217 216 218 232 156 58 42 46 51 153 171 210
209 217 215 225 151 57 38 42 49 145 158 197
Operating Profit 8 -1 4 7 5 2 4 4 2 9 13 13
OPM % 4% -0% 2% 3% 3% 3% 9% 8% 3% 6% 8% 6%
3 190 17 10 6 7 12 10 5 14 9 1
Interest 3 1 1 1 0 0 0 0 0 0 0 0
Depreciation 3 3 3 3 3 3 3 3 2 3 3 4
Profit before tax 6 186 17 14 7 5 13 11 5 19 19 10
Tax % 3% 19% 16% 3% 10% -5% 24% 20% 13% 29% 10% 24%
6 151 15 14 6 6 10 9 4 14 17 8
EPS in Rs 4.16 112.86 10.84 10.14 4.72 4.13 7.22 6.52 2.96 10.31 12.85 5.79
Dividend Payout % 36% 4% 15% 18% 42% 49% 31% 77% 102% 34% 14% 35%
Compounded Sales Growth
10 Years: 0%
5 Years: 38%
3 Years: 61%
TTM: 23%
Compounded Profit Growth
10 Years: -12%
5 Years: -8%
3 Years: 31%
TTM: -58%
Stock Price CAGR
10 Years: 1%
5 Years: 2%
3 Years: -17%
1 Year: -18%
Return on Equity
10 Years: 4%
5 Years: 4%
3 Years: 6%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 7 7 7 7 7 7 7 7 7 7 7 7
Reserves 46 190 208 219 223 223 233 238 235 145 157 163
22 8 7 5 0 0 0 0 0 1 0 0
49 46 52 50 21 10 12 10 12 37 38 42
Total Liabilities 123 251 274 280 250 240 251 255 254 189 202 212
36 37 38 37 36 36 34 32 28 26 33 40
CWIP 2 2 2 1 2 0 0 0 7 13 8 2
Investments 20 105 167 174 157 158 169 172 163 67 80 72
65 107 68 69 55 45 47 50 55 83 81 97
Total Assets 123 251 274 280 250 240 251 255 254 189 202 212

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
9 -28 -3 8 -16 2 4 -0 0 11 18 12
1 50 2 1 18 2 -3 2 7 -7 -10 -10
-8 -20 -1 -5 -7 -6 -0 -3 -7 -3 -6 -2
Net Cash Flow 1 2 -2 4 -5 -1 1 -1 0 1 3 0
Free Cash Flow 7 -31 -7 7 -18 1 3 -2 -5 6 14 -7
CFO/OP 123% -653% -39% 166% -305% 223% 180% 62% 65% 209% 153% 78%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 61 52 62 59 93 106 160 171 166 116 87 86
Inventory Days 45 42 54 41 30 57 86 50 45 57 60 57
Days Payable 76 71 86 87 44 77 160 108 119 128 124 103
Cash Conversion Cycle 29 23 30 13 78 86 86 114 92 46 23 40
Working Capital Days -11 83 17 13 76 207 278 295 224 63 44 65
ROCE % 11% 21% 1% 6% 3% 2% 5% 5% 1% 7% 11% 5%

Insights

In beta
Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue (FOB Basis)
INR Lakhs

Log in to view insights

Please log in to see hidden values.

Login
R&D Expenditure (Total)
INR Lakhs
Number of Permanent Employees (Standalone)
Count
Number of Manufacturing Plants
Count
Number of Group Employees (Consolidated)
Count
Specialty Chemicals Segment Revenue (Consolidated)
INR Lakhs
Animal Health Segment Revenue (Consolidated)
INR Lakhs
R&D Headcount at Alandi (Scientists, Engineers, Chemists)
Count

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
67.54% 67.54% 67.55% 67.55% 67.56% 67.61% 67.63% 67.65% 67.65% 67.65% 67.72% 68.08%
0.57% 0.59% 1.10% 0.94% 0.66% 0.69% 0.81% 0.61% 0.61% 0.61% 0.61% 0.61%
0.69% 0.69% 0.98% 1.18% 1.21% 1.18% 1.26% 1.32% 1.13% 0.74% 0.74% 0.74%
31.20% 31.18% 30.36% 30.32% 30.56% 30.52% 30.30% 30.42% 30.60% 31.00% 30.93% 30.58%
No. of Shareholders 9,4589,4809,81810,14510,84012,42913,40712,97913,48813,16812,67012,107

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents